324 related articles for article (PubMed ID: 29072946)
1. Histologic Mimics of Basal Cell Carcinoma.
Stanoszek LM; Wang GY; Harms PW
Arch Pathol Lab Med; 2017 Nov; 141(11):1490-1502. PubMed ID: 29072946
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.
Yang HM; Cabral E; Dadras SS; Cassarino DS
Am J Dermatopathol; 2008 Dec; 30(6):549-54. PubMed ID: 19033927
[TBL] [Abstract][Full Text] [Related]
3. Expression of drebrin, an actin binding protein, in basal cell carcinoma, trichoblastoma and trichoepithelioma.
Mizutani Y; Iwamoto I; Kanoh H; Seishima M; Nagata K
Histol Histopathol; 2014 Jun; 29(6):757-66. PubMed ID: 24346822
[TBL] [Abstract][Full Text] [Related]
4. Basaloid tumors arising from seborrheic keratosis: Malignant basal cell carcinoma or benign basaloid follicular hamartomatous proliferation?
Flordelis JO; Shen YC; Wu YH
J Cutan Pathol; 2020 Mar; 47(3):207-218. PubMed ID: 31682281
[TBL] [Abstract][Full Text] [Related]
5. Cytokeratin 20 expression in basaloid follicular hamartoma and infundibulocystic basal cell carcinoma.
Honarpisheh H; Glusac EJ; Ko CJ
J Cutan Pathol; 2014 Dec; 41(12):916-21. PubMed ID: 25353070
[TBL] [Abstract][Full Text] [Related]
6. Familial basaloid follicular hamartoma: lesional characterization and review of the literature.
Jih DM; Shapiro M; James WD; Levin M; Gelfand J; Williams PT; Oakey RJ; Fakharzadeh S; Seykora JT
Am J Dermatopathol; 2003 Apr; 25(2):130-7. PubMed ID: 12652194
[TBL] [Abstract][Full Text] [Related]
7. Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: a clinicopathologic and immunohistochemical study.
Plaza JA; Mackinnon A; Carrillo L; Prieto VG; Sangueza M; Suster S
Am J Dermatopathol; 2015 Nov; 37(11):809-21. PubMed ID: 26485238
[TBL] [Abstract][Full Text] [Related]
8. Molecular diagnosis of basal cell carcinoma and other basaloid cell neoplasms of the skin by the quantification of Gli1 transcript levels.
Hatta N; Hirano T; Kimura T; Hashimoto K; Mehregan DR; Ansai S; Takehara K; Takata M
J Cutan Pathol; 2005 Feb; 32(2):131-6. PubMed ID: 15606671
[TBL] [Abstract][Full Text] [Related]
9. Basaloid neoplasms in nevus sebaceus.
Kaddu S; Schaeppi H; Kerl H; Soyer HP
J Cutan Pathol; 2000 Aug; 27(7):327-37. PubMed ID: 10917159
[TBL] [Abstract][Full Text] [Related]
10. Basal cell carcinoma with sebaceous differentiation.
Misago N; Suse T; Uemura T; Narisawa Y
Am J Dermatopathol; 2004 Aug; 26(4):298-303. PubMed ID: 15249860
[TBL] [Abstract][Full Text] [Related]
11. Immunoreactivity for Sox10 in Basaloid Neoplasms of The Skin.
Bush JW; Gru AA; Wick MR
Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):114-118. PubMed ID: 30531326
[TBL] [Abstract][Full Text] [Related]
12. Basaloid tumors in nevus sebaceus revisited: the follicular stem cell marker PHLDA1 (TDAG51) indicates that most are basal cell carcinomas and not trichoblastomas.
Sellheyer K; Cribier B; Nelson P; Kutzner H; Rütten A
J Cutan Pathol; 2013 May; 40(5):455-62. PubMed ID: 23489134
[TBL] [Abstract][Full Text] [Related]
13. Cytokeratins as markers of follicular differentiation: an immunohistochemical study of trichoblastoma and basal cell carcinoma.
Kurzen H; Esposito L; Langbein L; Hartschuh W
Am J Dermatopathol; 2001 Dec; 23(6):501-9. PubMed ID: 11801790
[TBL] [Abstract][Full Text] [Related]
14. Utility of Ber-EP4 and MOC-31 in Basaloid Skin Tumor Detection.
Gill P; Naugler C; Abi Daoud MS
Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):584-588. PubMed ID: 29629953
[TBL] [Abstract][Full Text] [Related]
15. CD10 expression in trichoepithelioma and basal cell carcinoma.
Pham TT; Selim MA; Burchette JL; Madden J; Turner J; Herman C
J Cutan Pathol; 2006 Feb; 33(2):123-8. PubMed ID: 16420307
[TBL] [Abstract][Full Text] [Related]
16. Elastic fiber staining and cytokeratin 15 expression pattern in trichoepithelioma and basal cell carcinoma.
Choi CW; Park HS; Kim YK; Lee SH; Cho KH
J Dermatol; 2008 Aug; 35(8):499-502. PubMed ID: 18789069
[TBL] [Abstract][Full Text] [Related]
17. Basal cell carcinoma vs basaloid squamous cell carcinoma of the skin: an immunohistochemical reappraisal.
Webb DV; Mentrikoski MJ; Verduin L; Brill LB; Wick MR
Ann Diagn Pathol; 2015 Apr; 19(2):70-5. PubMed ID: 25702956
[TBL] [Abstract][Full Text] [Related]
18. PHLDA1 (TDAG51) is a follicular stem cell marker and differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma.
Sellheyer K; Krahl D
Br J Dermatol; 2011 Jan; 164(1):141-7. PubMed ID: 20846311
[TBL] [Abstract][Full Text] [Related]
19. Amelanotic malignant melanoma: two collision tumors presenting as basal cell carcinoma and atypical fibroxanthoma.
McGregor DH; Cherian R; Romanas MM; Ulusarac O; Mathur SC; Feldman MM
Ann Clin Lab Sci; 2008; 38(2):157-62. PubMed ID: 18469362
[TBL] [Abstract][Full Text] [Related]
20. Anti-cytokeratin 20 staining of Merkel cells helps differentiate basaloid proliferations overlying dermatofibromas from basal cell carcinoma.
Mahmoodi M; Asad H; Salim S; Kantor G; Minimo C
J Cutan Pathol; 2005 Aug; 32(7):491-5. PubMed ID: 16008693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
